Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

JHU083 is a prodrug form of the glutaminase inhibitor 6-diazo-5-oxo-L-nor-leucine (Item No. 17580).1 It decreases tumor volume, increases tumor microenvironment (TME) levels of Tnf-secreting macrophages, and increases survival in a B6CaP murine prostate cancer model.1 JHU083 increases tumor infiltration by Cd8+ T cells in a UN-SCC680 murine lung squamous cell carcinoma model.2 It also reduces granuloma area and lung weight and increases survival in M. tuberculosis-infected mice.3
WARNING This product is not for human or veterinary use.
1. Metabolic reprogramming of tumor-
2. Targeting glutamine metabolism to enhance immunoprevention of EGFR-
3. Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis. Nat. Commun. 14(1), 7427 (2023).